Floatz logo

2-ACETYLFURO-1,4-NAPHTHOQUINONE

Previously Treated Metastatic Colorectal Cancer

1Globe Health Institute LLCSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Previously Treated Metastatic Colorectal Cancer cohort.

Asset / SponsorPhaseRating
Guadecitabine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2CCC

Same molecule, other indications

2-ACETYLFURO-1,4-NAPHTHOQUINONE is also rated in:

pancreatic ductal adenocarcinomaDormant
B
Indicative ·
62 / 100
View asset →
colorectal cancerDormant
B
Indicative ·
61 / 100
View asset →
colorectal cancerDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →